GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (FRA:51B) » Definitions » Price-to-Free-Cash-Flow

Bioventix (FRA:51B) Price-to-Free-Cash-Flow : 19.49 (As of May. 22, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Bioventix Price-to-Free-Cash-Flow?

As of today (2025-05-22), Bioventix's share price is €33.00. Bioventix's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.69. Hence, Bioventix's Price-to-Free-Cash-Flow Ratio for today is 19.49.

The historical rank and industry rank for Bioventix's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:51B' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.95   Med: 28.72   Max: 39.08
Current: 19.41

During the past 13 years, Bioventix's highest Price-to-Free-Cash-Flow Ratio was 39.08. The lowest was 14.95. And the median was 28.72.

FRA:51B's Price-to-Free-Cash-Flow is ranked better than
63.56% of 225 companies
in the Biotechnology industry
Industry Median: 31.09 vs FRA:51B: 19.41

Bioventix's Free Cash Flow per Share for the six months ended in Dec. 2024 was €0.82. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €1.69.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bioventix was -5.90% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 10.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 6.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 16.20% per year.

During the past 13 years, Bioventix's highest 3-Year average Free Cash Flow per Share Growth Rate was 41.20% per year. The lowest was 1.30% per year. And the median was 21.80% per year.


Bioventix Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bioventix's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Price-to-Free-Cash-Flow Chart

Bioventix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.52 34.37 24.06 26.14 27.99

Bioventix Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 26.14 - 27.99 -

Competitive Comparison of Bioventix's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Bioventix's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioventix's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioventix's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bioventix's Price-to-Free-Cash-Flow falls into.


;
;

Bioventix Price-to-Free-Cash-Flow Calculation

Bioventix's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=33.00/1.693
=19.49

Bioventix's Share Price of today is €33.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioventix's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Bioventix  (FRA:51B) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Bioventix Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bioventix's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioventix Business Description

Traded in Other Exchanges
Address
27–28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.

Bioventix Headlines

No Headlines